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Abstract
Background—Adsorption of albumin onto urine collection and analysis containers may cause 
falsely low concentrations.
Methods—We added 125I-labeled human serum albumin to urine and to phosphate buffered 
solutions, incubated them with 22 plastic container materials and measured adsorption by liquid 
scintillation counting.
Results—Adsorption of urine albumin (UA) at 5–6 mg/l was <0.9%; and at 90 mg/l was <0.4%. 
Adsorption was generally less at pH 8 than pH 5 but only 3 cases had p <0.05. Adsorption from 11 
unaltered urine samples with albumin 5–333 mg/l was <0.8%. Albumin adsorption for the material 
with greatest binding was extrapolated to the surface areas of 100 ml and 2 l collection containers, 
and to instrument sample cups and showed <1% change in concentration at 5 mg/l and <0.5% 
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change at 20 mg/l or higher concentrations. Adsorption of albumin from phosphate buffered 
solutions (2–28%) was larger than that from urine.
Conclusions—Albumin adsorption differed among urine samples and plastic materials, but the 
total influence of adsorption was <1% for all materials and urine samples tested. Adsorption of 
albumin from phosphate buffered solutions was larger than that from urine and could be a 
limitation for preparations used as calibrators.
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1. Introduction
Chronic kidney disease is a significant public health problem worldwide, and diagnosis is 
hampered by the lack of standardized early detection methods. Urinary albumin (UA) 
measurement is widely used for detection of chronic kidney disease, but albumin adsorption 
to collection and analysis containers may cause falsely low measurements. A joint working 
group of the National Kidney Disease Education Program and the International Federation 
of Clinical Chemistry and Laboratory Medicine identified surface adsorption onto containers 
as one of the pre-analytical variables that could influence interpretation of urine albumin 
results especially at lower concentrations important for early detection [1].
Investigators have used both chemical and physical methods including radioisotopes [2], 
atomic force microscopy [3], fluorescence and infrared spectroscopy [4], and ellipsometry 
[5] to study the interactions of proteins with surfaces. Many have studied albumin adsorption 
in search of promising materials for use in implantable medical devices, but the albumin 
concentrations used in these studies approached the concentrations in human serum or 
plasma, which are considerably greater than those in urine. Only a few studies have 
examined albumin adsorption to containers at the concentrations found in human urine. 
Holmberg and Hou [6] reported on the competitive adsorption of proteins in buffered 
mixtures onto polymer surfaces and the complex nature of this process. A few investigators 
have reported adsorption onto particular containers [7] and explored the use of surfactants 
such as Triton X-100 and Tween-20 to reduce albumin adsorption [8]. Bakker reported up to 
90% reduction in albumin adsorption using surfactants [9]. Because the pH of urine varies 
widely, the influence of pH and surfactants are important considerations for measurement of 
albumin adsorption onto container surfaces.
2. Materials and methods
Fig. S1 (supplemental data) provides a flow chart showing the series of experimental 
components that are described in detail in the following sections.
2.1. Containers
We purchased urine collection containers, centrifuge tubes, storage vials, and sample 
analysis cups from companies indicated in Table S1 (supplemental data). The polyethylene 
terephthalate materials with a hydrophilic coating claiming to reduce bovine serum albumin 
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adsorption to 1/10,000 of that for polystyrene were donated by Sumitomo-Bakelite, Japan 
through their U.S. subsidiary Wako.
2.2. Labeled and unlabeled human serum albumin
We used custom-labeled 125I-HSA from Perkin Elmer (88–93 mCi/mg, in 0.01 mol/l sodium 
phosphate buffer, pH 7.4, containing 0.0027 mol/l KCl and 0.137 mol/l NaCl) to prepare 
mixtures of labeled and unlabeled HSA. HSA (crystallized cat # A8763-1G) was from 
Sigma-Aldrich Chemical Co. We assumed that 125I-HSA and unlabeled HSA had the same 
adsorption properties.
2.3. Urine and human serum albumin solutions
For adsorption studies using urine, we collected unidentified, fresh human urine samples or 
used leftover, unidentified urine samples from Grady Health System or Virginia 
Commonwealth University Hospital using a protocol approved by the CDC Human Subjects 
Review Committee. Urine samples were transported and stored at 4–8 °C and used within 30 
days of collection. We measured both albumin concentration and pH and used some of the 
samples without adjustment. We used some of the samples with very low urine albumin 
concentrations as baseline urine to dilute samples with higher concentrations (pooled urine). 
We prepared stock unlabeled HSA solutions (1 g/l) in both baseline urine and 10 mmol/l 
phosphate-buffered saline (PBS). From these stock solutions, we prepared dilutions to 
contain 5 and 100 mg/l. We adjusted these solutions to pH 4.0, 5.0, or 8.0 using 2 mol/l HCl 
or 2 mol/l NaOH just prior to adjusting the final volume. To examine the effects of 
surfactants, we prepared buffered HSA solutions to contain 0.1 v/v% Triton X-100 and 0.05 
v/v% Tween-20. We stored all solutions refrigerated in small aliquots in 20 ml glass liquid 
scintillation counting (LSC) vials and spiked with the 125I-HSA as needed to obtain specific 
activities of 107–1010 counts per minute/mg (cpm/mg). All chemicals were analytical grade.
2.4. Adsorption and retention measurements
We conducted adsorption studies by incubating container materials with urine samples or 
buffered HSA solutions at room temperature (23.0 ± 2.0 °C), for specific time periods 
(usually 300 min). Disks (1.032 cm diameter, 0.836 cm2) were punched from plastic 
materials when possible and 100 μl of solutions was placed on the surface. Instrument 
sample cups were filled with 200 μl of solutions which covered an area of approximately 
1.43 cm2. After incubation we transferred the solution, five water rinses, and the pipet tip to 
a glass LSC vial and the material (disk, cone, sample cup, or sample vial) to a separate 
counting vial. To calculate “total counts” we added the counts for both vials and used that 
total to calculate specific activity. This approach allowed us to measure both the albumin 
retained in solution and the albumin adsorbed onto the material. For some experiments, we 
only counted the material (disk, cup or vial) and prepared two separate vials using an equal 
volume of the solution incubated on the material (either 100 or 200 μl) to determine specific 
activity. For containers that could not be cut or transferred to LSC vials, we used the latter 
approach. In all cases, we added 10 ml of liquid scintillation cocktail (Ultima Gold, Perkin 
Elmer) to each vial and counted for 1 min with a Perkin Elmer Tri-carb 3100TR Liquid 
Scintillation Counter using a protocol for 125I. The counter was calibrated weekly with 3H 
and 14C reference solutions.
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We calculated specific activity (Sp.Ac.) according to the following equation:
Vol is the volume counted (100 μl for disks and 200 μl for cones, sample analysis cups or 
vials) and Cb is the total concentration of albumin (labeled + unlabeled). We calculated the 
albumin concentration in the labeled solution from data provided on the certificate of 
analysis. We measured the albumin concentration in both urine and buffered HSA solutions 
by immunoassay (IA) prior to spiking with 125I-labeled HSA, then calculated the total 
albumin concentration for use in the equation above. We measured albumin concentrations 
using IA with a Roche Hitachi 912 Clinical Analyzer using Roche Tina-Quant reagents, 
calibrators, and controls according to the manufacturer’s instructions. We also measured 
buffered HSA solutions with and without the surfactants to determine whether surfactants 
interfered with the albumin IA. We calculated the surface adsorption for each disk, cup, or 
other container according to the following equation:
To further support our 125I estimates of albumin retention in urine samples, we measured 
albumin concentrations in urine samples using IA before and after 10 serial transfers from 
one container to the next over 300 min (30 min intervals per container) in both polystyrene 
and hydrophilic-coated sample vials.
To measure the effects of pH on albumin concentration, we mixed 2 urine samples to obtain 
an albumin concentration of approximately 10 mg/l. We adjusted the pH of duplicate 3 ml 
aliquots to values from 4.0 to 9.5 in increments of 0.5 pH units with microliter quantities of 
2 mol/l NaOH or 2 mol/l HCl. After overnight refrigeration, we measured the albumin 
concentrations by IA; then re-adjusted each aliquot to pH 5.7 (the pH of the original pooled 
urine sample) and re-measured the albumin concentration.
Experiments to examine rinsing efficiency, effects of specific activity on adsorption 
measurements, and kinetics of adsorption are described in the Supplemental Data File. 
Because we were storing our samples in glass counting vials, we compared adsorption in 
glass and polystyrene counting vials. We also compared adsorption onto materials from the 
sides, bottoms, and tops of a single polypropylene container and compared adsorption onto 
surfaces of two types of 15 ml centrifuge tubes (hydrophilic-coated PET and polystyrene). 
We measured adsorption onto glass and polystyrene counting vials and conical bottoms of 
hydrophilic-coated PET and polystyrene centrifuge tubes. We compared surface adsorption 
onto disks cut from the bottom, sides, and top of one polypropylene urine collection cup. 
These data are also shown in the Supplemental Data File.
2.5. Experimental design
We used an approach outlined in Introduction to Design of Experiments with JMP, Third 
Edition published by the SAS Institute [10], to develop the experimental design. We selected 
albumin concentrations (5 and 100 mg/l), pHs (4.0, 5.0 and 8.0), and times (0.5 and 5.0 h), 
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and used published surfactant concentrations for Triton X-100 (0.1%) and for Tween-20 
(0.05%).
2.6. Statistical analysis
We performed measurements in quadruplicate (except where noted otherwise).
We used SAS to compute means or geometric means, standard deviations, and 95% 
confidence intervals. We used analysis of covariance, t-tests, and Duncan’s Multiple 
Comparison tests to determine statistical significance of differences in retention and 
adsorption across materials and conditions.
2.7. Extrapolation of results to clinical testing
To evaluate the influence of adsorption for typical urine collection conditions, we 
extrapolated the adsorption per cm2 results to the surface areas of a 100 ml container with 
dimensions 5.72 cm diameter and 7.32 cm height (surface area 182 cm2) as well as to a 3 l 
container with a 2 l fill with dimensions 11.43 cm square and 25.4 cm tall (surface area 905 
cm2). Our results did not account for differences in the surface-to-volume ratios or 
differences in diffusion rates between the urine containers and the volumes added to the 
plastic disks or instrument cups.
3. Results
3.1. Validation of experimental design conditions
The supplemental data includes information on several aspects of the experimental design. 
The kinetics of adsorption of albumin to surfaces was found to reach a maximum at 5–6 h 
(Fig. S2). Consequently, we used 5 h as the adsorption time recognizing that longer intervals 
would not change the adsorption proportion. The conditions thus were close to those for a 
random urine collection although no additional adsorption would be expected for longer 
times such as 24 h. Three rinses were sufficient to remove all non-adsorbed albumin from 
surfaces (Fig. S3). A stable measurement of adsorption occurred when the specific activity 
of 125I labeled HSA was 107 to 109 cpm/mg (Fig. S4). We determined that glass counting 
vials adsorbed significantly less albumin than polystyrene (p < 0.01), except for the higher 
albumin concentration at pH 8 (p = 0.51). The hydrophilic coated vials adsorbed 
significantly less albumin than polystyrene, p < 0.01 (Fig. S5).
3.2. Albumin adsorption onto container materials
Fig. 1 shows the adsorption of albumin from urine and from PBS solutions onto a number of 
different container materials. Note that not all materials were investigated in all experiments; 
however, the same numbers were used to identify the materials throughout the manuscript 
figures and tables. The numeric data and p values are in Tables S2 and S3 (supplemental 
data). Fig. 1A shows adsorption from low (5.3 mg/l at pH 5 and 5.8 mg/l at pH 8) and high 
(88 mg/l at pH 5 and 91 mg/l at pH 8) albumin concentrations in urine samples onto 2 types 
of instrument sample cups and disks from 16 types of container materials. The amount 
adsorbed differed among types of materials but was <1% for all, and was lower at pH 8 than 
at pH 5. Only 1 of 16 materials had a significant difference (p = 0.033) between the pHs at 
Robinson et al. Page 5
Clin Chim Acta. Author manuscript; available in PMC 2017 November 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
low albumin concentrations and 2 of 16 had a significant difference (p = 0.007 and 0.029) 
between the pHs at higher albumin concentrations. The amount of albumin retained in the 
urine applied to the plastics is shown in Table S4 (supplemental data). A mass balance of the 
albumin adsorbed onto surfaces and retained in the bulk solutions accounted for 99–101% of 
the albumin present in each condition, indicating no unexplained loss in the experimental 
manipulations (Table S4, supplemental data).
Fig. 1B shows adsorption from solutions of albumin in PBS at low (0.4 mg/l at pH 4 and 1.3 
mg/l at pH 8) and high (76 mg/l at pH 4 and 83 mg/l at pH 8) albumin concentrations, onto 2 
types of instrument sample cups and 18 types of container materials. The adsorption from 
PBS solutions was somewhat larger (2–7%) than from the urine samples for most of the 
materials. However, larger amounts of albumin were adsorbed from PBS solutions (7–28%) 
for polystyrene and polyethylene sample cups. At the lower albumin concentrations, the 
influence of pH on adsorption could not be evaluated because the albumin concentrations 
differed by 3-fold which was sufficient to contribute to the different absolute amounts 
adsorbed. For the higher albumin concentrations, adsorption at pH 8 was less than at pH 4 
for 18 of 20 materials but only 6 of 20 differences in adsorption at the 2 pHs were 
statistically significant (p = 0.029 to <0.001).
Fig. 2 shows adsorption from 11 urine samples with albumin concentrations of 5–333 mg/l 
and pH values of 4.8–7.5 onto 2 types of instrument sample cups and 2 types of container 
materials. The amount adsorbed differed among urine samples and material types. There was 
scatter in the data, but a general increase in the amount adsorbed occurred as the 
concentration in the bulk solution increased.
Fig. 3 shows that the surfactants Triton X-100 and Tween-20 significantly decreased the 
adsorption of albumin to PE and PS sample cups, and Fig. S6 (supplemental data) shows the 
same for PP disks; p < 0.001 for all three materials for both surfactants. However, Fig. S7 
(supplemental data) shows that the surfactants caused an interference in the IA used here and 
consequently may not be generally useful for urine albumin sample collection or storage.
Because the adsorption of albumin to surfaces was relatively small, we investigated the 
influence of 10 serial transfers of albumin solutions over 5 h to new polystyrene or 
hydrophilic-coated polyethylene terephthalate vials. Table 1 shows that the change in 
albumin concentrations was −3.5% to 2.4%, except for one urine sample which changed 
−8.9% for PS instrument sample cups.
3.3. Effects of pH on albumin measurements
Fig. S8 (supplemental data) shows that urine supplemented with HSA had a substantial 
decrease in albumin concentration measured by IA below pH 5. Readjusting the pH to its 
original values caused an increase in concentrations but did not fully restore the albumin 
concentrations to their original values.
3.4. Extrapolation of results to clinical testing
The influence of albumin adsorption on the clinical interpretation of results is shown in 
Table 2 based on the data in Fig. 2 for measurements of albumin adsorption from urine 
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samples to 2 types of instrument sample cups and 2 types of plastic. Table S5 shows a 
similar clinical impact assessment for urine samples adsorbed to 18 plastic surfaces at 2 
urine albumin concentrations and 2 pHs. Using either type of data, the influence of 
adsorption was proportionally greater at lower concentrations and caused <1% change in 
albumin concentration at 5 mg/l and <0.5% change at the clinical decision threshold of 20 
mg/l.
4. Discussion
The focus of this study was to measure the influence of albumin adsorption onto a variety of 
material surfaces that may be used for collection, storage, and measurement of albumin in 
urine. Our primary goal was to determine whether adsorption of urine albumin onto 
collection and analysis containers would compromise the ability to measure urine albumin 
accurately at concentrations used to detect early kidney disease.
The total amount of albumin adsorbed increased as the concentration in urine increased. 
However, the influence of adsorption on concentration was greater at lower urine 
concentrations because the amount adsorbed was a larger fraction of the total concentration. 
Albumin adsorption from urine samples with approximately the same concentrations was 
seen to vary considerably, and this variability could be influenced by differences in the urine 
matrix [11]. Based on worst case adsorption conditions, we concluded that albumin 
adsorption onto urine collection containers and instrument analysis cups was <1% (>0.05 
mg/l) at 5 mg/l, <0.5% (<0.1 mg/l) at the frequently used decision threshold of 20 mg/l and 
proportionally less at higher concentrations. Consequently, adsorption of albumin is not 
likely to influence interpretation of results in clinical situations.
The trivial amount of albumin adsorption could be minimized, if desired, by alkalinization 
or buffering of samples, by limiting the number of transfers of urine to different containers, 
and by selection of container materials for which albumin adsorption has been found to be 
minimal. Overall, the order of least adsorption of albumin onto materials was hydrophilic-
coated polyethylene terephthalate < polypropylene < glass < polystyrene < polyethylene. 
There were very few statistically or clinically significant differences in adsorption of 
albumin between pHs of 5 and 8 for urine samples. However, for HSA in PBS at a 
concentration of approximately 80 mg/l, there were several conditions with significantly 
more adsorption at pH 4 than at pH 8.
Albumin adsorption was larger from PBS solutions than from urine samples at comparable 
albumin concentrations. This observation is not surprising since urine contains a variety of 
other components that may modify the adsorption of albumin to the surface. However, 
adsorption should be considered and minimized for preparation, storage and use of buffered 
albumin solutions as reference materials for calibration of measurement procedures.
The most significant apparent losses of albumin from urine and buffered HSA solutions 
occurred at pH values <5. The albumin concentrations of some of the HSA solutions 
prepared by weight to be 5 mg/l, were close to zero at pH 4.0 using the Roche Tina-Quant 
IA. We conclude that urine albumin concentration measured using this IA may be falsely 
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low when the urine pH is below 5.0. The molecular conformation of albumin changes 
between pH 5.0 and 3.5. The molecule changes from the native, N conformation to an 
electrophoretically faster-moving F conformation known as the N–F transition. This 
transition is thought to involve structural changes in the helix that may cause irreversible 
denaturation [12] affecting albumin’s stability, its adsorption characteristics and its 
immunoreactivity in some measurement procedures. Heerspink et al. [13] reported that urine 
alkalinization to pH N >8.0 prevented the decline in UA concentration otherwise observed 
during prolonged frozen storage at −20 °C for urine samples from diabetic patients. These 
observations lead us to postulate that alkalinization or buffering of fresh urine samples may 
be a useful component of a standardized protocol for UA measurement using IA.
Adding surfactants to the urine appeared to reduce the adsorption of albumin. However, 
there was an artifactual influence of the surfactants on the IA measurement procedure used 
which limited any general conclusions. However, given the small influence of adsorption to 
containers, using surfactants to reduce adsorption would not improve the clinical 
interpretation of results.
4.1. Strengths
Strengths of this investigation were that we were careful to limit the number of transfers of 
solutions to 2 and we did not centrifuge any of the samples. The primary conclusions were 
based on adsorption from native urine samples and reinforced by data from solutions of 
buffered HSA. Radioactively labeled albumin was used to quantitate the adsorption, making 
conclusions independent of a typical IA or other chemical measurement procedure. The 
mass balance of albumin adsorbed from or retained in solutions indicated that there were no 
unexplained losses of albumin.
4.2. Limitations
Limitations of this study include the small numbers and concentration ranges of native urine 
samples that we tested. Our extrapolation of adsorption losses to urine containers based on 
data collected by incubation on 1.032 cm diameter disks of plastic materials or on fixed 
small volumes in sample cups assumed similar rates of diffusion and did not correct for 
differences in surface-to-volume ratios. Uettwiller et al. [14] showed that adsorption 
decreases along with the surface-to-volume ratios (R). For our disks, urine collection cups, 
and 24-h collection containers, the values of R were 8.36, 1.82 and 0.45 cm2/ml which 
means that adsorption onto the urine collection cups and 24-h collection container would be 
even less than that shown by our data. Mixing of urine in a container would increase the rate 
of diffusion from the bulk solution to the surface which would increase the potential amount 
adsorbed. Consequently, the adsorption extrapolation to larger containers represented a 
worse case situation. The surface areas of the plastic disks were all the same (0.836 cm2), 
however, the actual contact areas varied because the 100 μl of liquid did not completely 
cover the disk. The differences in contact area were not corrected for, but would have a 
minimal influence on conclusions because the disks were nearly completely covered with a 
thin film of liquid.
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4.3. Conclusions
Albumin adsorption differed among urine samples and plastic materials, but the total 
influence of adsorption was <1% for all materials and urine samples tested and unlikely to 
cause erroneous assessment of an individual’s albumin excretion. Adsorption of albumin 
from phosphate buffered solutions was larger than from urine and could be a limitation for 
preparations used as calibrators.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
UA urinary albumin
HSA human serum albumin
IA immuno-turbidimetric assay
LSC liquid scintillation counting
Sp.Ac specific activity
HPET hydrophilic-coated polyethylene terephthalate
PE polyethylene
PP polypropylene
PS polystyrene
PET polyethylene terephthalate
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Fig. 1. 
Adsorption of albumin onto plastic materials. Panel A shows adsorption from urine samples. 
Panel B shows adsorption from HSA in PBS. Materials 1–19 were disks cut from: 
hydrophilic-coated centrifuge tube (1), polystyrene centrifuge tube (2 & 12), polypropylene 
urine specimen containers (3, 4, 6, 11 & 13), polyethylene urine specimen containers (5 & 
18), polyethylene terephthalate centrifuge tube (7), polypropylene centrifuge tubes (8, 9, 10, 
& 15), tef centrifuge tube (14), polyethylene 24-h urine collection jug (16), polysulfone 
centrifuge tube (17), and polypropylene screw cap for container #3 (19). Materials 20–22 
were: polystyrene sample cups (20), hydrophilic coated vials (21), polyethylene sample cups 
(22).
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Fig. 2. 
Adsorption of albumin from 11 urine samples. The lines are second order polynomial fits to 
the data; the equation for material 16 (worst case) is y = 2.68 × 10−4 (x2) + 0.160 (x) + 2.38. 
Plot symbols are: material 3 (triangle), material 16 (diamond), sample cup material 20 
(square), hydrophilic vial material 21 (circle) for the same materials described in Fig. 1.
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Fig. 3. 
Albumin adsorbed to polyethylene (PE) and polystyrene (PS) instrument sample cups from 
200 μl of 88 mg/l HSA in PBS plus 125I-labeled HSA after incubation for 5 h in the absence 
and presence of the surfactants Triton X-100 (Tr) and Tween 20 (Tw). Results are the mean 
of 4 measurements, and bars represent 95% confidence intervals.
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Table 1
Adsorption of albumin to sample cups after 10 transfers.
Sample Materiala
Albumin concentration, mg/l
Changec, %Initial After 10 transfersb
HSA in PBS PS 12.7 13.1 3.1
HSA in PBS PS 30.3 30.6 1.0
Urine PS 25.9 23.6 −8.9
HSA in PBS HPET 13.0 2.4
HSA in PBS HPET 30.1 −0.7
Urine HPET 25.0 −3.5
a
Materials were: PS, polystyrene instrument cup; HPET, hydrophilic coated vial.
b
Incubation was for 5 h with 10 sequential transfers to a new cup or vial at 30 min intervals.
cChange in concentration vs. initial values.
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